One of the key things we can do to retain patients on clinical trials – and also because it just seems to be the right thing to do – is reduce the burden of participation. People taking part in trials are volunteers in the process, so making it as easy as possible for them would certainly appear to be a good idea.

Sadly, this is not always the case when you look at what’s involved – the multiple site visits, the recording of Patient Reported Outcomes, the sometimes debilitating procedures that have to be undertaken, the general disruption to a person’s daily routine etc.

Which is why I always recommend having patient involvement from the outset when designing a trial – so you can incorporate their feedback into the protocol, and help to reduce the number of people who drop out of trials due to the burden of participation.

You may also like

Biotech C-suites Should keep Patient Recruitment in Mind from the Outset
In biotech, a strong C-suite isn’t just about job titles - it’s about covering every part of the journey from discovery to delivery. Including being prepared to tackle one of the biggest ...
Key C-suite Roles for Biotech Success - The Chief Patient Recruitment Officer (CPRO)
While biotech companies have built C-suites with scientific, medical, financial, operational, and business expertise, a critical function has remained conspicuously absent - addressing one ...
Key C-suite Roles for Biotech Success - The Chief Business Officer (CBO)
The Chief Business Officer leads external strategy - licensing deals, identifying pharma partnerships, and developing long-term growth planning and market positioning strategies that ...